Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics

@article{Riba2003HumanPO,
  title={Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics},
  author={J. Riba and Marta Valle and G. Urbano and M. Yritia and A. Morte and M. Barbanoj},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2003},
  volume={306},
  pages={73 - 83}
}
  • J. Riba, Marta Valle, +3 authors M. Barbanoj
  • Published 2003
  • Medicine
  • Journal of Pharmacology and Experimental Therapeutics
    • The effects of the South American psychotropic beverage ayahuasca on subjective and cardiovascular variables and urine monoamine metabolite excretion were evaluated, together with the drug's pharmacokinetic profile, in a double-blind placebo-controlled clinical trial. [...] Key Method Eighteen volunteers with prior experience in the use of psychedelics received single oral doses of encapsulated freeze-dried ayahuasca (0.6 and 0.85 mg of DMT/kg of body weight) and placebo. Ayahuasca produced significant…Expand Abstract
    View on ASPET
    catbull.com
    233 Citations
    Highly Influencial Citations
    27
    Background Citations
    108
    Methods Citations
    11
    Results Citations
    10
    233 Citations
    Citation Type

    Citation Type

    Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca: A Comparative Study With d-Amphetamine
    • 85
    Pharmacology of ayahuasca administered in two repeated doses
    • 69
    Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
    • 56
    • PDF
    Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study
    • 154
    • PDF
    Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans
    • 34
    • Highly Influenced
    • PDF
    Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.
    Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers
    • 38
    • PDF
    Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography
    • 100
    • PDF
    Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment
    • 83
    Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review
    • 8
    • PDF

    References

    SHOWING 1-10 OF 45 REFERENCES
    Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
    • 183
    • PDF
    Pharmacokinetics of Hoasca alkaloids in healthy humans.
    • 224
    • Highly Influential
    • PDF
    Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects.
    • 160
    Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans.
    • 317
    • PDF
    Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled study
    • 125
    • PDF
    Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.
    • 132
    • PDF
    Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.
    • 216
    • Highly Influential
    Determination of N,N-dimethyltryptamine and beta-carboline alkaloids in human plasma following oral administration of Ayahuasca.
    • M. Yritia, J. Riba, +5 authors M. Barbanoj
    • Chemistry, Medicine
    • Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
    • 2002
    • 75
    Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
    • 274
    • Highly Influential
    Abuse liability of flunitrazepam among methadone-maintained patients
    • 47
    • Highly Influential
    • PDF